MR功能成像对肝细胞癌微血管侵犯的评估价值

王莉莉; 李俊峰; 窦郁; 郭顺林; 雷军强

doi:10.3969/j.issn.1001-5256.2018.12.038

MR功能成像对肝细胞癌微血管侵犯的评估价值

DOI: 10.3969/j.issn.1001-5256.2018.12.038

1. 兰州大学第一医院放射科
2. 兰州大学第一医院传染科传染病研究所

基金项目:

国家自然科学基金青年基金项目(81800528)； 2018年甘肃省卫生行业科研计划项目(GSWSKY2018-24)； 2018年兰州市城关区科技发展计划项目(2018SHFZ0023)；

详细信息

中图分类号: R735.7;R445.2
计量
- 文章访问数: 1600
- HTML全文浏览量: 12
- PDF下载量: 335
- 被引次数: 29
出版历程
- 出版日期: 2018-12-20

Value of magnetic resonance functional imaging in evaluating microvascular invasion of hepatocellular carcinoma

Research funding:

摘要

摘要: 微血管侵犯作为预测肝细胞癌术后复发的指标目前只能通过"金标准"病理组织学确诊,常规影像学检查方法和血清学指标的检测在微血管侵犯研究中敏感度及特异度均较低,如果术前能够对其作出预测和评估,对于临床治疗方式的选择及患者预后的评估具有重要价值。近年来MR功能成像技术及新型对比剂发展较快,在肝细胞癌早期诊断和术后疗效随访及复发评估方面是研究的热点。简述了利用磁共振扩散加权成像的定量表观扩散系数对肝细胞癌微血管评估的意义,以及体素内不相干运动MR成像、扩散峰度成像新型扩散模型对其评估的潜在价值,同时分析了动态增强磁共振成像及钆塞酸二钠特异性增强MR对肝细胞癌是否存在微血管侵犯及预测其术后复发的应用现状。分析表明MR功能成像技术的发展及部分新技术的应用对肝细胞癌微血管侵犯的评估具有重要价值,可以进一步评估其术后复发及转移的风险,为临床早期诊断、合理采用手术及治疗方式提供可靠的定量评价指标。
- 癌,肝细胞 /
- 磁共振成像 /
- 微血管侵犯 /
- 综述
Abstract: Microvascular invasion, as a predictive factor for postoperative recurrence of hepatocellular carcinoma (HCC) , can only be diagnosed by the gold standard of pathological histology at present. Conventional imaging examination and serological markers have low sensitivity and specificity in evaluating microvascular invasion. Preoperative prediction and evaluation of microvascular invasion has an important value in selecting clinical treatment and assessing patient diagnosis. In recent years, magnetic resonance (MR) functional imaging and new contrast agents have been developing rapidly and have become the research hotspots in early diagnosis of HCC, postoperative follow-up of treatment outcome, and recurrence evaluation. This article elaborates on the significance of apparent diffusion coefficient of diffusion-weighted magnetic resonance imaging in evaluating microvascular invasion, as well as the potential value of intravoxel incoherent motion-magnetic resonance imaging and a new diffusion model of diffusion kurtosis imaging. This article also analyzes the application of dynamic contrast-enhanced magnetic resonance imaging and Gd-EOB-DTPA-specific MR in evaluating microvascular invasion and predicting postoperative recurrence. The analysis shows that the development of MR functional imaging and the application of several new techniques play an important role in the assessment of microvascular invasion of HCC and can determine the risk of postoperative recurrence and metastasis and provide reliable quantitative assessment indices for early diagnosis and reasonable application of surgery and other treatment methods.
- carcinoma, hepatocellular /
- magnetic resonance imaging /
- microvascularinvasion /
- review

HTML全文

参考文献(29)

[1] SAPISOCHIN G, CASTELLS L, DOPAZO C, et al. Single HCC in cirrhotic patients:Liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis[J]. Ann Surg Oncol, 2013, 20 (4) :1194-1202.

[2] WU HL, ZHENG SJ, DUAN ZP. Route of metastasis of primary hepatic carcinoma from the perspective of anatomy[J]. J Clin Hepatol, 2017, 33 (10) :2009-2015. (in Chinese) 伍慧丽, 郑素军, 段钟平.从解剖学角度探讨原发性肝癌的转移途径[J].临床肝胆病杂志. 2017, 33 (10) :2009-2015.

[3] CHOI JY, LEE JM, SIRLIN CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma:part I. Development, growth, and spread:Key pathologic and imaging aspects[J]. Radiology, 2014, 272 (3) :635-654.

[4] RODRIGUEZ-PERALVAREZ M, LUONG TV, ANDREANA L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma:Diagnostic and prognostic variability[J]. Ann Surg Oncol, 2013, 20 (1) :325-339.

[5] QI YP, ZHONG JH, LIANG ZY, et al. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion[J]. Am J Surg, 2018.[Epub ahead of print]

[6] YE JZ, CHEN JZ, LI ZH, et al. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion[J]. World J Gastroenterol, 2017, 23 (41) :7415-7424.

[7] ADLER M, LAROCCA L, TROVATO FM, et al. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by Fibro Scan:A multicentre study[J]. HPB (Oxford) , 2016, 18 (8) :678-683.

[8] LI JW, LING WW, LU Q, et al. Liver stiffness and serum alphafetoprotein in discriminating small hepatocellular carcinoma from cirrhotic nodule[J]. Ultrasound Q, 2016, 32 (4) :319-326.

[9] BAILLY M, VENEL Y, ORAIN I, et al. 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma:Predicting histology?[J]. Clin Nucl Med, 2016, 41 (3) :e126-e129.

[10] YANG C, WANG H, SHENG R, et al. Microvascular invasion in hepatocellular carcinoma:Is it predictable with a new, preoperative application of diffusion-weighted imaging?[J]. Clin Imaging, 2017, 41:101-105.

[11] UNAL E, IDILMAN IS, AKATA D, et al. Microvascular invasion in hepatocellular carcinoma[J]. Diagn Interv Radiol, 2016, 22 (2) :125-132.

[12] SUH YJ, KIM MJ, CHOI JY, et al. Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusionweighted imaging[J]. Liver Transpl, 2012, 18 (10) :1171-1178.

[13] XU P, ZENG M, LIU K, et al. Microvascular invasion in small hepatocellular carcinoma:Is it predictable with preoperative diffusion-weighted imaging?[J]. J Gastroenterol Hepatol, 2014, 29 (2) :330-336.

[14] ZHAO J, LI X, ZHANG K, et al. Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging:A comparison of mean and minimum apparent diffusion coefficient values[J]. Medicine (Baltimore) , 2017, 96 (33) :e7754.

[15] LEE S, KIM SH, HWANG JA, et al. Pre-operative ADC predicts early recurrence of HCC after curative resection[J]. Eur Radiol, 2018.[Epub ahead of print]

[16] LI H, ZHANG J, ZHENG Z, et al. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma[J]. Eur J Radiol, 2018, 105:65-71.

[17] WOO S, LEE JM, YOON JH, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma:Correlation with enhancement degree and histologic grade[J]. Radiology, 2014, 270 (3) :758-767.

[18] ZHAO W, LIU W, LIU H, et al. Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusionweighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging[J]. PLo S One, 2018, 13 (5) :e0197488.

[19] ROSENKRANTZ AB, SIGMUND EE, WINNICK A, et al. Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices:Preliminary experience in fresh liver explants[J]. Magn Reson Imaging, 2012, 30 (10) :1534-1540.

[20] WANG WT, YANG L, YANG ZX, et al. Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging[J].Radiology, 2018, 286 (2) :571-580.

[21] WU TH, HATANO E, YAMANAKA K, et al. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma[J]. Surg Today, 2016, 46 (11) :1275-1281.

[22] SHIRABE K, KAJIYAMA K, ABE T, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma:Measurement of portal perfusion defect area ratio[J]. J Gastroenterol Hepatol, 2009, 24 (8) :1431-1436.

[23] AHN SY, LEE JM, JOO I, et al. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18) F-FDG PET/CT[J]. Abdom Imaging, 2015, 40 (4) :843-851.

[24] SUN Y, ZHANG N, HOU J, et al. Value of Gd-EOB-DTPAenhanced MRI in diagnosis of hepatocellular carcinoma[J]. J Clin Hepatol, 2018, 34 (1) :129-132. (in Chinese) 孙玉, 张楠, 侯洁, 等.钆塞酸二钠MRI对肝细胞癌的诊断价值[J].临床肝胆病杂志, 2018, 34 (1) :129-132.

[25] KIM KA, KIM MJ, JEON HM, et al. Prediction of microvascular invasion of hepatocellular carcinoma:usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images[J]. J Magn Reson Imaging, 2012, 35 (3) :629-634.

[26] NISHIE A, ASAYAMA Y, ISHIGAMI K, et al. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2014, 29 (3) :561-567.

[27] SHIN SK, KIM YS, SHIM YS, et al. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma:A STROBE-compliant article[J]. Medicine (Baltimore) , 2017, 96 (33) :e7761.

[28] MIN JH, KIM YK, LIM S, et al. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging:Impact of intra-tumoral fat detected on chemicalshift images[J]. Eur J Radiol, 2015, 84 (6) :1036-1043.

[29] KIM MJ, LEE M, CHOI JY, et al. Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging[J]. Eur J Radiol, 2012, 81 (10) :2507-2512.

施引文献

期刊类型引用(17)

1.	杨文帅，王立坤，董聪慧，武永萍，石栓柱. 瞬时弹性成像技术联合血清游离脂肪酸对非酒精性脂肪性肝病的诊断价值. 转化医学杂志. 2024(09): 1330-1335 . 百度学术
2.	崔会鹏，田昊宇，关琳，李异玲. 代谢相关性脂肪性肝病无创诊断方法研究进展. 胃肠病学和肝病学杂志. 2022(01): 99-103 . 百度学术
3.	凡军芳，胡静，耿旭，庄兰艮，时照明. 2型糖尿病患者肝脏受控衰减参数与血清25-羟维生素D的相关性. 中华全科医学. 2021(05): 794-797 . 百度学术
4.	陈雅洁，李昭贤，王洋，曹经琳，窦剑. 瞬时弹性成像技术在肝移植围手术期应用的研究进展. 中华器官移植杂志. 2021(08): 501-504 . 百度学术
5.	林俊红，林常青，翁娜，刘宴伟. 中年女性高血压体检者体质指数异常与脂肪肝发病率的相关性研究及护理干预. 全科护理. 2020(10): 1212-1214 . 百度学术
6.	张晓静，林淑珍，张志安，温美兰. FibroTouch技术在诊断非酒精性脂肪性肝病患者肝脂肪变程度中的应用. 临床医学. 2020(04): 79-80 . 百度学术
7.	李萍英，李娟，谢守珍，杨永耿，陆伦根. FibroTouch联合超声和CT检查诊断高原地区非酒精性脂肪性肝病临床应用研究. 实用肝脏病杂志. 2020(06): 817-820 . 百度学术
8.	李正鑫，陈洋溢，赵志敏，吕靖，陈高峰，刘成海. 基于肝脏病理学对慢性乙型肝炎肝硬化患者FibroTouch测量值的影响因素分析. 临床肝胆病杂志. 2019(02): 338-344 . 本站查看
9.	陈中淑. 超声检查在诊断脂肪肝方面的临床应用价值. 当代医药论丛. 2019(10): 26-28 . 百度学术
10.	何义华，罗建君，文安怡，程志生，余志映，吴舒婷. 二至解酲汤治疗酒精性肝病临床研究. 中医学报. 2018(06): 1099-1102 . 百度学术
11.	何妙峰. 腹部B超对健康体检者脂肪肝筛查的价值分析. 深圳中西医结合杂志. 2018(10): 90-91 . 百度学术
12.	王晴晴，胡明芬，杨红洁，禹蔚琴，柏保利，匡小林，庄林. B超在慢性HBV携带者合并非酒精性脂肪性肝病诊断中的应用. 肝脏. 2018(08): 723-727 . 百度学术
13.	王新. 脂肪肝与病毒性肝炎B超鉴别诊断结果的对比研究. 心理月刊. 2018(04): 47-48 . 百度学术
14.	张志伟. 肝功能与血清学指标水平检验对脂肪肝的诊断价值分析. 中外医疗. 2018(34): 11-13 . 百度学术
15.	南胜天. CT及B超在脂肪肝临床诊断中应用的价值. 甘肃科技. 2017(07): 102-103 . 百度学术
16.	庄小芳，孙洁，王晓波，王燕，吴琦琦，王晓忠. 瞬时弹性成像技术诊断非酒精性脂肪性肝病的性能评估. 临床肝胆病杂志. 2017(12): 2366-2371 . 本站查看
17.	杨杰，曹玉芝，徐永升，王雪，刘闯. 373例非酒精性脂肪性肝病FibroTouch检测临床观察. 中国实用医药. 2017(24): 33-34 . 百度学术